483
Hetero Labs Limited - Unit IIIHetero Labs Limited - Unit III – FDA 483, Oct 26, 2018
Record Details
An FDA inspection of Hetero Labs, Ltd. - Unit III in Hyderabad, India, revealed significant deficiencies in their drug manufacturing processes. Observations included a lack of established control procedures to monitor output and validate manufacturing process performance, leading to inconsistent processes and failed batches. Additionally, master production and control records were found to be missing theoretical yield specifications.
View Company Profile
ID · 3adb6ed3-d4b8-482d-aecf-624f8ceb7aa5
Other documents for Hetero Labs Limited - Unit III
- 483 - 2025-09-26
- 483 - 2023-07-21
- 483 - 2019-06-07
- 483 - 2018-03-23
- 483 - 2016-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.